// App-Quantinova.ai

: The efficacy of immune checkpoint inhibitors in biliary tract cancer with KRAS mutation.

Researchers

Presenter

  • Sun Young Jeong

Principal Investigators

  • Seung Tae Kim

  • Jae Yeon Jang

Medical Centers

  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • KRAS proto-oncogene, GTPase

  • Programmed death-ligand 1

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved